Opioid Receptor, delta, Rat, aa358-372, Control Peptide

Catalog No : USB-O7030-05A
348.29€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name Opioid Receptor, delta, Rat, aa358-372, Control Peptide
Catalog No USB-O7030-05A
Supplier’s Catalog No O7030-05A
Supplier US Biologicals
Source antigen Synthetic peptide
Reactivity
Cross reactivity
Applications
Molecular weight 1060.1
Storage 4°C
Other names
Grade Purified
Purity Purified (HPLC)
Form Lyophilized. Reconstitute initially in a small volume of 25% acetonitrile in water or 25% ethanol in water to make a concentrated stock solution and dilute aqueous buffer.
Reactivity life 12 months
Note For reserch purpose only
Purity Purified (HPLC)
Description The function of the delta-opioid receptors has not been determined. However, recent studies in rodents have linked delta-opioid receptor antagonists with prevention of morphine tolerance and dependence without relinquishing mu-opioid antinociception. In general, opioids modulate numerous central and peripheral processes, including pain perception, neuroendocrine secretion and the immune response. The opioid signal is transduced from receptors through G proteins to various different effectors. Subsequent to G protein activation, several effectors are known to orchestrate the opioid signal. For example, activation of opioid receptors increases phosphatidylinositol turnover, activates K+ channels and reduces adenylyl cyclase and Ca++ channel activities. Control Peptide for Opioid Receptor, delta, O7030-05 Peptide Sequence (linear): Synthetic peptide: TACTPSDGPGGGAAA, corresponding to amino acids 358-372 of Rat Delta Opioid Receptor. Purity: >99% HPLC. 100% Form: Supplied as a lyophilized powder Molecular Weight: 1233D Storage and Stability: Lyophilized powder may be stored at 4°C for short-term only. Stable for 12 months at -20°C. Reconstitute to nominal volume (see reconstitution instructions for peptides) and store at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.